C119H158F14N24O8 — CID 157343810
4-[[4-[[(1S,2S)-2-(2,2-difluoroethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(dimethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(ethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(piperidine-1-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide (PubChem CID 157343810) has the molecular formula C119H158F14N24O8 and a molecular weight of 2318.70 g/mol. Its IUPAC name is 4-[[4-[[(1S,2S)-2-(2,2-difluoroethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(dimethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(ethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(piperidine-1-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide.
| Compound Name | 4-[[4-[[(1S,2S)-2-(2,2-difluoroethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(dimethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(ethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(piperidine-1-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide |
|---|---|
| PubChem CID | 157343810 |
| Molecular Formula | C119H158F14N24O8 |
| Molecular Weight | 2318.70 g/mol |
| Exact Mass | 2317.25 |
| IUPAC Name | 4-[[4-[[(1S,2S)-2-(2,2-difluoroethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(dimethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;4-[[4-[[(1S,2S)-2-(ethylcarbamoyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(piperidine-1-carbonyl)cyclohexyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide |
| SMILES | CCNC(=O)[C@H]1CCCC[C@H]1Cc1nc(Nc2ccc(C(=O)N(C)C3CCN(C)CC3)cc2)ncc1C(F)(F)F.CN1CCC(N(C)C(=O)c2ccc(Nc3ncc(C(F)(F)F)c(C[C@@H]4CCCC[C@@H]4C(=O)N(C)C)n3)cc2)CC1.CN1CCC(N(C)C(=O)c2ccc(Nc3ncc(C(F)(F)F)c(C[C@@H]4CCCC[C@@H]4C(=O)N4CCCCC4)n3)cc2)CC1.CN1CCC(N(C)C(=O)c2ccc(Nc3ncc(C(F)(F)F)c(C[C@@H]4CCCC[C@@H]4C(=O)NCC(F)F)n3)cc2)CC1 |
| InChI | InChI=1S/C32H43F3N6O2.C29H37F5N6O2.2C29H39F3N6O2/c1-39-18-14-25(15-19-39)40(2)29(42)22-10-12-24(13-11-22)37-31-36-21-27(32(33,34)35)28(38-31)20-23-8-4-5-9-26(23)30(43)41-16-6-3-7-17-41;1-39-13-11-21(12-14-39)40(2)27(42)18-7-9-20(10-8-18)37-28-36-16-23(29(32,33)34)24(38-28)15-19-5-3-4-6-22(19)26(41)35-17-25(30)31;1-36(2)27(40)23-8-6-5-7-20(23)17-25-24(29(30,31)32)18-33-28(35-25)34-21-11-9-19(10-12-21)26(39)38(4)22-13-15-37(3)16-14-22;1-4-33-26(39)23-8-6-5-7-20(23)17-25-24(29(30,31)32)18-34-28(36-25)35-21-11-9-19(10-12-21)27(40)38(3)22-13-15-37(2)16-14-22/h10-13,21,23,25-26H,3-9,14-20H2,1-2H3,(H,36,37,38);7-10,16,19,21-22,25H,3-6,11-15,17H2,1-2H3,(H,35,41)(H,36,37,38);9-12,18,20,22-23H,5-8,13-17H2,1-4H3,(H,33,34,35);9-12,18,20,22-23H,4-8,13-17H2,1-3H3,(H,33,39)(H,34,35,36)/t23-,26-;19-,22-;2*20-,23-/m0000/s1 |
| InChIKey | BGSFJBRLDSDSLW-ZKTQBURFSA-N |
| XLogP | 20.63 |
| TPSA | 344.26 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 165 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2318.70 |
| LogP ≤ 5 | 20.63 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 24 |